1. Therapeutic Strategies in COPD Focus on Patient Characteristics and Drug Delivery

3. The Burden of COPD

4. The Burden of COPD (cont)

5. Impact of COPD Exacerbations

6. Therapies Used in COPD

7. Goals of Therapy

8. Personalize Therapy

9. Risk Assessment

10. Risk Assessment (cont)

11. Strategies to Reduce the Risk of Acute Exacerbations of COPD

12. Therapies to Reduce the Risk of Acute Exacerbations of COPD

13. Factors to Consider When Choosing a Drug Delivery Device

14. The Significance of Peak Inspiratory Flow Rate (PIFR)

15. Manual Dexterity and MDIs

16. Arformoterol: Long-term Safety Data From the 2013 American Thoracic Society Meeting

17. Arformoterol: Long-term Safety Data From the 2013 American Thoracic Society Meeting (cont)

18. Results

19. Make et al Data From the 2013 American Thoracic Society Meeting

20. Results

21. Efficacy and Safety of the Once-Daily Inhaled Umeclidinium/Vilanterol Combination in COPD

22. Results

23. Long-term Safety Study of Aclidinium/Formoterol

24. Summary of Advances in COPD

25. Abbreviations

26. References

27. References (cont)

28. References (cont)